| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |